U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.4242+10T>C AND not specified

Germline classification:
Benign/Likely benign (2 submissions)
Last evaluated:
Mar 6, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000079004.16

Allele description [Variation Report for NM_000492.4(CFTR):c.4242+10T>C]

NM_000492.4(CFTR):c.4242+10T>C

Gene:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.4242+10T>C
HGVS:
  • NC_000007.14:g.117665574T>C
  • NG_016465.4:g.204791T>C
  • NM_000492.4:c.4242+10T>CMANE SELECT
  • LRG_663t1:c.4242+10T>C
  • LRG_663:g.204791T>C
  • NC_000007.13:g.117305628T>C
  • NM_000492.3:c.4242+10T>C
Links:
dbSNP: rs138642693
NCBI 1000 Genomes Browser:
rs138642693
Molecular consequence:
  • NM_000492.4:c.4242+10T>C - intron variant - [Sequence Ontology: SO:0001627]
Observations:
2

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000110873Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Benign
(May 24, 2013)
germlineclinical testing

Citation Link,

SCV000697014Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely benign
(Mar 6, 2024)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown2not providednot providednot providednot providedclinical testing

Citations

PubMed

Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling.

Le Maréchal C, Audrézet MP, Quéré I, Raguénès O, Langonné S, Férec C.

Hum Genet. 2001 Apr;108(4):290-8.

PubMed [citation]
PMID:
11379874

Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results.

Tabor HK, Auer PL, Jamal SM, Chong JX, Yu JH, Gordon AS, Graubert TA, O'Donnell CJ, Rich SS, Nickerson DA; NHLBI Exome Sequencing Project., Bamshad MJ.

Am J Hum Genet. 2014 Aug 7;95(2):183-93. doi: 10.1016/j.ajhg.2014.07.006. Epub 2014 Jul 31.

PubMed [citation]
PMID:
25087612
PMCID:
PMC4129409
See all PubMed Citations (4)

Details of each submission

From Eurofins Ntd Llc (ga), SCV000110873.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided2not providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000697014.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

Variant summary: CFTR c.4242+10T>C alters a conserved nucleotide located at a position not widely known to affect splicing. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00038 in 281870 control chromosomes (gnomAD), predominantly at a frequency of 0.004 within the African or African-American subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in CFTR causing Cystic Fibrosis (0.00038 vs 0.013), allowing no conclusion about variant significance. c.4242+10T>C has been reported in the literature in individuals screened for Cystic Fibrosis or other CFTR-related disorders (e.g. Marechal_2001, El-Seedy_2016). These reports do not provide unequivocal conclusions about association of the variant with Cystic Fibrosis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 28040058, 28408918, 11379874, 25087612). ClinVar contains an entry for this variant (Variation ID: 53928). Based on the evidence outlined above, the variant was classified as likely benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024